Canadian firm's implant controls glucose in diabetic pigs

07/12/2010 | Reuters

Diabetic pigs treated with Sernova's Cell Pouch System showed long-term normal glucose levels without experiencing adverse events, according to preclinical trials. The implantable device uses insulin-producing tissues, or islets, derived from the pancreas of the animals to enable the therapeutic cells to thrive and function in a natural environment.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD